Metastatic melanoma (used in combination with dabrafenib for improved treatment outcomes).
Treatment of non-small cell lung carcinoma.
Treatment of metastatic anaplastic thyroid cancer.
Treatment of metastatic solid tumours.
Therapeutic Effects:
Works by blocking the activity of a protein called Mitogen-activated protein kinase kinase (MEK), which is part of the Mitogen-activated protein kinase (MAPK) signaling pathway.
Helps slow or stop cancer cell growth and spread by blocking MEK.
Interaction with Other Drugs:
Inform your doctor about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Meqsel 0.5mg Tablet and reduce effectiveness by causing undesirable side effects.
Storage:
Store at room temperature between 68°F to 77°F (20°C to 25°C).
Keep in original packaging.
Protect from light and moisture.
Keep out of the reach of children and pets.
How to Consume:
Usually taken orally as a tablet.
Can be taken either with or without food.
Follow the instructions provided by the healthcare provider or pharmacist.
Swallow whole with a full glass of water.
Do not crush, chew, or break the tablet.
If a dose is missed, take it as soon as possible unless it is almost time for the next scheduled dose.
Safety Advices:
Pregnancy: unsafe for pregnant women as it may cause foetal harm.
Breastfeeding: unsafe during breastfeeding.
Lungs: consult your doctor if you have any lung diseases before starting the treatment.
Liver: regular monitoring of liver function tests is recommended.
Alcohol: avoid or limit alcohol intake.
Driving: may cause side effects such as fatigue, dizziness, or blurred vision that can impair a patient's ability to drive or operate machinery safely.
Side Effects:
Serious: heart failure, irregular heartbeat, shortness of breath, liver injury or hepatitis, retinal detachment, gastrointestinal perforation, Stevens-Johnson syndrome.
Common: nausea, diarrhoea, fatigue, skin rash, acne, dry skin, headache, fever, swelling in the hands or feet, high blood pressure, eye problems, such as blurred vision or sensitivity to light.
Word of Advice:
Follow the instructions provided by your healthcare provider.
Promptly report any side effects or concerns.
Avoid alcohol.
Attend all scheduled appointments and follow-up visits with your healthcare provider.
FAQs:
Q 1. Can Meqsel 0.5mg Tablet cause hair loss?
Hair loss is not a common side effect, but some patients can experience hair thinning or hair loss during treatment.
Q 2. Can I take Meqsel 0.5mg Tablet with multivitamins?
It is generally safe to take multivitamins while taking Meqsel 0.5mg Tablet. However, it is important to talk to your healthcare provider before taking any new medications or supplements, including multivitamins.
Q 3. In how much time will Meqsel 0.5mg Tablet show effect?
The time it takes for Meqsel 0.5mg Tablet to show its effects can vary depending on the type and stage of the cancer being treated and other individual factors.
Q 4. Can Meqsel 0.5mg Tablet cause vision loss?
Vision loss is a rare but potentially serious side effect. In clinical trials, less than 1% of patients experienced vision loss while taking it.
Q 5. Whether Meqsel 0.5mg Tablet is safe to use during pregnancy?
Meqsel 0.5mg Tablet is not recommended for use during pregnancy.
Q 6. Can I take Meqsel 0.5mg Tablet with milk?
Meqsel 0.5mg Tablet should not be taken with milk or other calcium-rich foods or beverages. Calcium can bind and reduce its absorption into the body, which can decrease its effectiveness.